ANCA-ASSOCIATED VASCULITIS: HETEROGENEITY OF CLINICAL MANIFESTATIONS, PROGNOSIS, CURRENT OPPORTUNITIES OF PHARMACOTHERAPY

ANCA-ASSOCIATED VASCULITIS: HETEROGENEITY OF CLINICAL MANIFESTATIONS, PROGNOSIS, CURRENT OPPORTUNITIES OF PHARMACOTHERAPY

The article highlights the new views on classification and nomenclature of systemic vasculitis, the meaning of detection of antineutrophil cytoplasmic antibodies (ANCA) in the diagnosis and prognosis of the disease. The literature data and own research regarding clinical manifestations of ANCA-assoc...

Full description

Bibliographic Details
Main Authors:	O.B. Yaremenko, L.B.
Format:	Article
Language:	English
Published:	Bogomolets National Medical University 2017-11-01
Series:	Медична наука України
Subjects:	anca-associated vasculitis, granulomatosis with polyangiitis, clinical features, prognosis, immunobiological therapy, rituximab
Online Access:	https://msu-journal.com/index.php/journal/article/view/53

Similar Items

COVID-19 in a patient with ANCA-associated systemic vasculitis, receiving anti-B cell therapy (rituximab)
by: T. V. Beketova, et al.
Published: (2018-06-01)

Recommendations of the Brazilian Society of Rheumatology for the induction therapy of ANCA-associated vasculitis
by: Alexandre Wagner Silva de Souza, et al.

The course and outcomes of COVID-19 in patients with ANCA-associated systemic vasculitis, receiving biological therapy (Rituximab, Mepolizumab): The results of the first 8 months of the pandemic
by: T. V. Beketova, et al.
Published: (2021-03-01)

ANCA Associated Mononeuritis Multiplex with Overlap in Vasculitic Syndromes
by: Ravi Anadure, et al.
Published: (2017-01-01)

THE 2016 EUROPEAN (EULAR/ERA-EDTA) RECOMMENDATIONS FOR THE DIAGNOSIS AND MANAGEMENT OF ANCA-ASSOCIATED SYSTEMIC VASCULITIS
by: T. V. Beketova
Published: (2017-03-01)

Granulomatosis with polyangiitis with severe lung involvement: efficacy of anti-B cell therapy with Rituximab
by: T. V. Beketova, et al.
Published: (2021-07-01)

Antineutrophil cytoplasmic antibody-associated vasculitis, update on molecular pathogenesis, diagnosis, and treatment
by: Arman F, et al.
Published: (2018-11-01)

Primary Vasculitis in Childhood: GPA and MPA in Childhood
by: Mehul P. Jariwala, et al.
Published: (2018-08-01)

Diagnostic algorithm for antineutrophil cytoplasmic antibody-associated systemic vasculitis
by: T V Beketova
Published: (2018-05-01)

Health-related quality of life in ANCA-associated vasculitis and item generation for a disease-specific patient-reported outcome measure
by: Robson JC, et al.
Published: (2018-01-01)

Clinical characteristics and long-term survival differences of the ANCA-associated vasculitis group: a cross-sectional study of 27 patients
by: Jolanta Dadonienė, et al.
Published: (2017-07-01)

A Candidate Gene Approach to ANCA-Associated Vasculitis Reveals Links to the C3 and CTLA-4 Genes but not to the IL1-Ra And Fcγ-RIIa Genes
by: Ulf Persson, et al.
Published: (2013-12-01)

GRANULOMATOSIS WITH POLYANGIITIS: TREAT THE PATIENT NOT SYMPTOMS
by: Makharynska O. S., et al.
Published: (2018-07-01)

Ophthalmologic manifestations of granulomatosis with polyangiitis (Wegener’s granulomatosis)
by: Ya O Grusha, et al.
Published: (2015-12-01)

Granulomatosis with polyangiitis: a 17 year experience from a tertiary care hospital in Pakistan
by: Omar Irfan, et al.
Published: (2018-05-01)

Eosinophils in anti-neutrophil cytoplasmic antibody associated vasculitis
by: Thomas Hellmark, et al.
Published: (2019-03-01)

Trend and Geographic Disparities in the Mortality Rates of Primary Systemic Vasculitis in the United States from 1999 to 2019: A Population-Based Study
by: Alicia Rodriguez-Pla, et al.
Published: (2021-04-01)

Galactosylation and Sialylation Levels of IgG Predict Relapse in Patients With PR3-ANCA Associated Vasculitis
by: Michael J. Kemna, et al.
Published: (2017-03-01)

Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis
by: Frank B. Cortazar, et al.
Published: (2018-03-01)

CLINICAL AND LABORATORY FEATURES OF ANCA ASSOCIATED VASCULITIS: EXPERIENCE AT A TERTIARY CARE HOSPITAL IN LAHORE, PAKISTAN
by: Muhammad Zeeshan Aslam, et al.
Published: (2021-02-01)

Gastrointestinal Involvement in Granulomatosis with Polyangiitis: Case Report and Review
by: Sahil Bagai, et al.
Published: (2019-01-01)

Granulomаtosis With Polyangiitis Affecting the Lung and Orbit
by: Zh. V. Sheikh, et al.
Published: (2021-06-01)

GENETIC SUSCEPTIBILITY TO ANCA-ASSOCIATED VASCULITIS: STATE OF THE ART
by: Francesco eBonatti, et al.
Published: (2014-11-01)

Rituximab, Cyclophosphamide, and Corticosteroids for ANCA Vasculitis: The Good, the Bad, and the Ugly
by: Roberta Fenoglio, et al.
Published: (2020-10-01)

Individualization of the ANCA associated vasculitis treatment
by: Zbigniew Zdrojewski
Published: (2014-09-01)

Successful total hip arthroplasty in patients with anca-associated systemic vasculitis
by: T. V. Beketova, et al.
Published: (2019-11-01)

Rituximab Induction and Maintenance in ANCA-Associated Vasculitis: State of the Art and Future Perspectives
by: Elena Treppo, et al.
Published: (2021-08-01)

Rituximab in relapsed/refractory antineutrophil cytoplasmic antibody associated vasculitis: A single-center prospective observational study
by: Ekbote Gayatri, et al.
Published: (2019-01-01)

Severe ophthalmic manifestation in pituitary-involved granulomatosis with polyangiitis: a case report and literature review
by: Xia Zhang, et al.
Published: (2018-11-01)

CD27+CD38hi B Cell Frequency During Remission Predicts Relapsing Disease in Granulomatosis With Polyangiitis Patients
by: Anouk von Borstel, et al.
Published: (2019-09-01)

Meningoensefalitis Manifestation in Wegener's Granulomatosis with Anca Negative: Case Report
by: Triyanti Kurniasari Ananta Putri Sudibyo, et al.
Published: (2019-09-01)

Evolution of views on ANCA-associated glomerulonephritis
by: T V Beketova, et al.
Published: (2008-12-01)

Anti-neutrophil cytoplasmic antibodies in rheumatoid arthritis: two case reports and review of literature
by: Spoerl David, et al.
Published: (2012-12-01)

Favorable efficacy of rituximab in ANCA-associated vasculitis patients with excessive B cell differentiation
by: Yusuke Miyazaki, et al.
Published: (2020-06-01)

International guidelines for the management ofANCA-associated systemic vasculitides
by: T. V. Beketova
Published: (2019-03-01)

Staphylococcus Aureus carriage and long-term Rituximab treatment for Granulomatosis with polyangiitis
by: Emilio Besada, et al.
Published: (2015-06-01)

ASYMPTOMATIC COURSE OF LUNG DAMAGE IN GRANULOMATOSIS WITH POLYANGIITIS (WEGENER’S)
by: Tat’yana V Beketova
Published: (2014-03-01)

Eosinophilic granulomatosis with polyangiitis: an overview
by: Andrea eGioffredi, et al.
Published: (2014-11-01)

Central Nervous System Involvement in ANCA-Associated Vasculitis: What Neurologists Need to Know
by: Yang Zheng, et al.
Published: (2019-01-01)

Ten-year experience with rituximab for induction and maintenance therapy in patients with ANCA-associated systemic vasculitis
by: T. V. Beketova, et al.
Published: (2020-03-01)

Cannot write session to /tmp/vufind_sessions/sess_la83q2j1mti4uhlp2o1vbdehc5